Expression of Basic Fibroblast Growth Factor, Vascular Endothelial Growth Factor, and Thrombospondin‐1 Related to Microvessel Density in Nonaggressive and Aggressive Basal Cell Carcinomas

The aggressive forms of basal cell carcinoma (BCC) are biologically different in a number of features from their nonaggressive counterparts. The expression of basic Fibroblast Growth Factor (bFGF), Vascular Endothelial Growth Factor (VEGF), and Thrombospondin‐1 (TSP‐1) was examined in primary culture samples of nonaggressive and aggressive BCCs. We studied the relationship between neoangiogenesis by counting microvessels, tumor aggressiveness, and the expression of three different angiogenic factors. bFGF mRNA was detectable in all BCC samples, but there was no significant difference in the levels of expression between the two types. VEGF mRNA was also detectable in all BCC samples. VEGF expression in the aggressive type was approximately 3.5‐fold higher than in the nonaggressive type. TSP‐1 expression was variable and not related to the type of BCC. The mean value of microvessel density (MVD) was significantly higher for the aggressive type than for the nonaggressive type. There was a significant correlation between VEGF levels and MVD. No significant relationships were found between bFGF, TSP‐1 mRNA expression, and MVD. In conclusion, the results of present study suggest that VEGF expression and angiogenesis might play important roles in the progression to aggressive BCC.

[1]  N. Sheibani Thrombospondin‐1, PECAM‐1, and Regulation of Angiogenesis , 2006, Histology and histopathology.

[2]  R. K. Bright,et al.  Thrombospondin‐1 expression and clinical implications in malignant pleural mesothelioma , 1999, Cancer.

[3]  N. Fusenig,et al.  Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[4]  G. Neufeld,et al.  Vascular endothelial growth factor (VEGF) and its receptors , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  David W. Dawson,et al.  CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells , 1997, The Journal of cell biology.

[6]  K. Yanagisawa,et al.  Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines. , 1996, Cancer research.

[7]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[8]  D. Roberts,et al.  Regulation of tumor growth and metastasis by thrombospondin‐1 , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  G. de Rosa,et al.  The prognostic significance of tumor angiogenesis in nonaggressive and aggressive basal cell carcinoma of the human skin. , 1996, Human pathology.

[10]  A. Anichini,et al.  Interaction with fibronectin regulates cytokine gene expression in human melanoma cells , 1996, International journal of cancer.

[11]  Yasuhiko Hayashi,et al.  Possible Participation of Autocrine and Paracrine Vascular Endothelial Growth Factors in Hypoxia-induced Proliferation of Endothelial Cells and Pericytes (*) , 1995, The Journal of Biological Chemistry.

[12]  A. Eisen,et al.  Matrix metalloproteinases in blood vessel development in human fetal skin and in cutaneous tumors. , 1995, The Journal of investigative dermatology.

[13]  R. Kerbel,et al.  Extent of vascularization as a prognostic indicator in thin (< 0.76 mm) malignant melanomas. , 1994, The American journal of pathology.

[14]  W Blumenfeld,et al.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. , 1993, The American journal of pathology.

[15]  A. Lee,et al.  Microvessel quantitation and prognosis in invasive breast carcinoma. , 1992, Human pathology.

[16]  D. Macdonald,et al.  Keratinocyte expression of CD36 antigen in benign and malignant epidermal cell‐derived tumours , 1991, Journal of cutaneous pathology.

[17]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[18]  D. Jones,et al.  Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. , 1990, Journal of the American Academy of Dermatology.

[19]  J. Wolf,et al.  Tumor angiogenic factor and human skin tumors. , 1975, Archives of dermatology.

[20]  S. Nishiyama [CAPILLARY DEMONSTRATION BY ALKALINE PHOSPHATASE STAINING IN DIFFERENT DERMATOSES. VI. EPITHELIAL TUMORS]. , 1964, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[21]  D. Moscatelli,et al.  The FGF family of growth factors and oncogenes. , 1992, Advances in cancer research.